The driving objective behind SOMARTEX (Self Operating MARine Trapping EXtractor) is to ensure the protection of marine invertebrate biodiversity while meeting the need to provide the drug pipeline with marine natural scaffolds and bioactive compounds. The main principle is the trapping of invertebrate holobionts molecules in their natural habitat at any location and depth, without harvesting the organism. SOMARTEX is patented and was financed independently by CNRS. The technology will be validated and exploited within the TASCMAR project.